Insider Selling: Masimo Corporation (MASI) Insider Sells 25,000 Shares of Stock

Masimo Corporation (NASDAQ:MASI) insider Jon Coleman sold 25,000 shares of the stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jon Coleman also recently made the following trade(s):

  • On Tuesday, April 25th, Jon Coleman sold 50,000 shares of Masimo Corporation stock. The stock was sold at an average price of $100.00, for a total value of $5,000,000.00.

Masimo Corporation (MASI) opened at 85.78 on Friday. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71. The stock has a market capitalization of $4.46 billion, a price-to-earnings ratio of 14.06 and a beta of 0.80. The stock’s 50 day moving average price is $91.26 and its 200 day moving average price is $90.35.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. The business had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.57 EPS. On average, analysts forecast that Masimo Corporation will post $2.80 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.com-unik.info/2017/08/19/insider-selling-masimo-corporation-masi-insider-sells-25000-shares-of-stock-updated-updated-updated.html.

Several hedge funds have recently added to or reduced their stakes in MASI. Koch Industries Inc. increased its stake in Masimo Corporation by 5,053.7% in the second quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after buying an additional 435,325 shares during the last quarter. 1st Global Advisors Inc. increased its stake in Masimo Corporation by 3.2% in the second quarter. 1st Global Advisors Inc. now owns 7,468 shares of the medical equipment provider’s stock worth $681,000 after buying an additional 233 shares during the last quarter. Sterling Capital Management LLC increased its stake in Masimo Corporation by 0.6% in the second quarter. Sterling Capital Management LLC now owns 7,803 shares of the medical equipment provider’s stock worth $711,000 after buying an additional 44 shares during the last quarter. Ameritas Investment Partners Inc. increased its stake in Masimo Corporation by 4.8% in the second quarter. Ameritas Investment Partners Inc. now owns 17,559 shares of the medical equipment provider’s stock worth $1,601,000 after buying an additional 802 shares during the last quarter. Finally, Intellectus Partners LLC acquired a new stake in shares of Masimo Corporation during the second quarter worth $237,000. Institutional investors and hedge funds own 84.14% of the company’s stock.

Several research analysts recently weighed in on the company. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BidaskClub lowered Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Stifel Nicolaus assumed coverage on Masimo Corporation in a research report on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective for the company. Finally, Wedbush reiterated an “outperform” rating and issued a $112.00 price objective on shares of Masimo Corporation in a research report on Monday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $95.00.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Insider Buying and Selling by Quarter for Masimo Corporation (NASDAQ:MASI)

What are top analysts saying about Masimo Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit